Journal
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 66, Issue 1, Pages 131-137Publisher
HUMANA PRESS INC
DOI: 10.1007/s12013-012-9461-z
Keywords
Neural stem cells; Homocysteine; Proliferation; ERK signaling; In vitro
Funding
- National Natural Science Foundation of China [81072289, 30901192]
Ask authors/readers for more resources
The aim of the present study was to determine if the excitatory amino acid homocysteine (Hcy) alters ERK signaling and cell proliferation in fetal neural stem cells (NSCs) in vitro. NSCs were isolated from fetal rats and grown in serum-free suspension medium. The cells were identified as NSCs by their expression of immunoreactive Sox2. NSCs were assigned to one of four treatment groups: vehicle control, low-dose Hcy group (Hcy-L, medium contained 30 mu mol/L Hcy), middle-dose Hcy group (Hcy-M, 100 mu mol/L Hcy) and high-dose Hcy group (Hcy-H, 300 mu mol/L Hcy). Cell proliferation was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Protein expression levels of ERK1/2 and phosphorylated ERK1/2 were detected by Western blot. The effects of Hcy on NSC death, including apoptosis, were assessed by using flow cytometry and trypan blue exclusion. The results showed that NSCs grew as neurospheres in the serum-free medium. Hcy decreased ERK1/2 protein phosphorylation and NSC proliferation, but it did not induce cell death or apoptosis within the concentration from 30 to 300 mu mol/L. The above results are consistent with the hypothesis that Hcy decreases fetal NSC proliferation by inhibiting ERK signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available